Skip to main content
PCRX logo

Pacira BioSciences, Inc.

PCRXNASDAQHealthcareDrug Manufacturers - Specialty & Generic

$36.33Today:- (-)1Y +59.55%

As of Oct 15, 2026 close

Market cap
$1.46B
P/E (TTM)
100.02
Forward P/E
-
Dividend yield
-
52-week range
$18.80$36.48
Volume (live)
-
Avg. volume (3M)
1.85M

Pacira BioSciences, Inc. (PCRX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Pacira BioSciences, Inc. stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Hold
Based on 10 unique analysts
(18 total ratings in last 90 days)
High Confidence0

Average Price Target

$32.86
−9.55% downside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest PCRX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Douglas Tsao
HC Wainwright
HoldDowngrades
$38.00 → $36.50
Daniel Clark
Leerink Partners
HoldReiterates
$28.00 → $36.50
Douglas Miehm
RBC Capital
HoldReiterates
$25.00 → $36.50
Dennis Ding
Jefferies
HoldDowngrades
$36.00
Les Sulewski
Oppenheimer
HoldDowngrades
-
Serge Belanger
Needham
HoldDowngrades
-
Douglas Miehm
RBC Capital
HoldInitiates Coverage
$25.00 → $36.50
Anish Nikhanj
Truist
HoldDowngrades
$31.00 → $36.50
Serge Belanger
Needham
BuyMaintains
$33.00
Les Sulewski
Oppenheimer
BuyInitiates
$32.00
Anish Nikhanj
Truist
BuyReiterates
-
Daniel Clark
Leerink Partners
HoldInitiates
$28.00
Anish Nikhanj
Truist
BuyMaintains
-
Jenna Davidner
Barclays
HoldMaintains
$25.00
Hardik Parikh
JP Morgan
SellMaintains
$23.00
Douglas Tsao
HC Wainwright
BuyReiterates
$38.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Douglas Miehm
RBC Capital
HoldMaintains
$24.00 → $25.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 9, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for PCRX?

The analyst consensus rating for PCRX is Hold, based on the latest ratings from 10 analysts over the last 90 days.

What is the average price target for PCRX?

The average 12-month price target for PCRX is $32.86, representing a downside of 9.6% from the Oct 15, 2026 close of $36.33.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.